These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Delayed presentation of prolonged hyperinsulinaemic hypoglycaemia in a preterm small-for-gestational age neonate. Chong JH; Chandran S; Agarwal P; Rajadurai VS BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24351577 [TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Touati G; Poggi-Travert F; Ogier de Baulny H; Rahier J; Brunelle F; Nihoul-Fekete C; Czernichow P; Saudubray JM Eur J Pediatr; 1998 Aug; 157(8):628-33. PubMed ID: 9727845 [TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with diazoxide in childhood hyperinsulinism. Grant DB; Dunger DB; Burns EC Acta Endocrinol Suppl (Copenh); 1986; 279():340-5. PubMed ID: 3465173 [TBL] [Abstract][Full Text] [Related]
11. Ten years' experience of persistent hyperinsulinaemic hypoglycaemia of infancy. Tyrrell VJ; Ambler GR; Yeow WH; Cowell CT; Silink M J Paediatr Child Health; 2001 Oct; 37(5):483-8. PubMed ID: 11885714 [TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects. Balachandran B; Mukhopadhyay K; Sachdeva N; Walia R; Attri SV Acta Paediatr; 2018 Jun; 107(6):990-995. PubMed ID: 29385640 [TBL] [Abstract][Full Text] [Related]
13. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism. Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644 [TBL] [Abstract][Full Text] [Related]
14. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation. Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534 [TBL] [Abstract][Full Text] [Related]
15. [Continuous treatment with diazoxide of hypoglycemia due to hyperinsulinism]. Loyau G; Kopp J; Sauvalle A; Porin J Sem Hop; 1970 Jun; 46(27):1907-10. PubMed ID: 4316119 [No Abstract] [Full Text] [Related]
16. When is it best to discontinue diazoxide in children with persistent hyperinsulinaemic hypoglycaemia and negative genetics for K Güemes M; Kostopoulou E; AlYahyaei M; Gilbert C; Shah P Clin Endocrinol (Oxf); 2022 Feb; 96(2):107-113. PubMed ID: 34370339 [TBL] [Abstract][Full Text] [Related]
17. Diazoxide for hyperinsulinism. Drug Ther Bull; 1970 Mar; 8(6):23-4. PubMed ID: 5440617 [No Abstract] [Full Text] [Related]
18. Transient lactic acidosis and hyperalaninaemia associated with neonatal hyperinsulinaemic hypoglycaemia: the effects of dichloroacetate (DCA). Aynsley-Green A; Weindling AM; Soltész G; Jenkins PA Eur J Pediatr; 1983 Dec; 141(2):114-7. PubMed ID: 6662140 [TBL] [Abstract][Full Text] [Related]
19. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy. Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248 [TBL] [Abstract][Full Text] [Related]
20. [Clinical observations and experimental findings in the treatment of hyperinsulinism with diazoxide]. Frerichs H; Creutzfeldt C; Creutzfeldt W Verh Dtsch Ges Inn Med; 1967; 73():1086-91. PubMed ID: 5591740 [No Abstract] [Full Text] [Related] [Next] [New Search]